Abstract:Human jaw bone marrow mesenchymal stem cells (h-JBMMSCs) are multipotent progenitor cells with osteogenic differentiation potential. The relationship between adiponectin (APN) and the metabolism of h-JBMMSCs has not been fully elucidated, and the underlying mechanism remains unclear. The aim of the study was to investigate the effect and mechanism of APN on h-JBMMSC metabolism. h-JBMMSCs were obtained from the primary culture of human jaw bones and treated with or without APN (1 µg/mL). Osteogenesis-related gene expression was evaluated by real-time polymerase chain reaction (PCR), alkaline phosphatase (ALP) activity assay, and enzyme-linked immunosorbent assay (ELISA). To further investigate the signaling pathway, mechanistic studies were performed using Western blotting, immunofluorescence, lentiviral transduction, and SB202190 (a specific p38 inhibitor). Alizarin Red staining showed that APN promoted h-JBMMSC osteogenesis. Real-time PCR, ALP assay, and ELISA showed that ALP, osteocalcin (OCN), osteopontin, and integrin-binding sialoprotein were up-regulated in APN-treated cells compared to untreated controls. Immunofluorescence revealed that adaptor protein containing a pleckstrin homology domain, phosphotyrosine domain, and leucine zipper motif (APPL1) translocated from the nucleus to the cytoplasm with APN treatment. Additionally, the phosphorylation of p38 mitogen-activated protein kinase (MAPK) increased over time with APN treatment. Moreover, knockdown of APPL1 or p38 MAPK inhibition blocked the expression of APN-induced calcification-related genes including ALP, Runt-related transcription factor 2 (RUNX2), and OCN. Furthermore, Alizarin Red staining of calcium nodes was not increased by the knockdown of APPL1 or p38 inhibition. Our data suggest that this regulation is mediated through the APPL1-p38 MAPK signaling pathway. These findings collectively provide evidence that APN induces the osteogenesis of h-JBMMSCs through APPL1-mediated p38 MAPK activation.

Apelin Suppresses Apoptosis of Human Osteoblasts

Apelin and Its Receptor Are Expressed in Human Osteoblasts

Apelin Stimulates Proliferation and Suppresses Apoptosis of Mouse Osteoblastic Cell Line MC3T3-E1 Via JNK and PI3-K/Akt Signaling Pathways.

Effect of apelin on human osteoblasts

Apelin Suppresses Apoptosis of Human Vascular Smooth Muscle Cells Via APJ/PI3-K/Akt Signaling Pathways

Apelin Plays A Catabolic Role On Articular Cartilage: In Vivo And In Vitro Studies

Apelin Attenuates the Osteoblastic Differentiation of Vascular Smooth Muscle Cells

Apelin-13 induces mitophagy in bone marrow mesenchymal stem cells to suppress intracellular oxidative stress and ameliorate osteoporosis by activation of AMPK signaling pathway

Apelin Inhibits Adipogenesis and Lipolysis Through Distinct Molecular Pathways

Apelin-13, a regulator of autophagy, apoptosis and inflammation in multifaceted bone protection

Apelin decreases lipolysis via G(q), G(i), and AMPK-Dependent Mechanisms

Correction: Apelin Ameliorates TNF-α-Induced Reduction of Glycogen Synthesis in the Hepatocytes Through G Protein-Coupled Receptor APJ

Regulation of Apelin-13 on Bcl-2 and Caspase-3 and Its Effects on Adipocyte Apoptosis

Novel Pathogenesis: Regulation of Apoptosis by Apelin/APJ System

The Apelinergic System: Apelin, ELABELA, and APJ Action on Cell Apoptosis: Anti-Apoptotic or Pro-Apoptotic Effect?

Adiponectin Promotes Human Jaw Bone Marrow Stem Cell Osteogenesis

Apelin Protects Against Liver X Receptor-Mediated Steatosis Through AMPK and PPARα in Human and Mouse Hepatocytes.

The apelin-13 peptide protects the heart against apoptosis through the ERK/MAPK and PI3K/AKT signaling pathways.

Apelin-13 Increases Expression of ATP-binding Cassette Transporter A1 Via Activating Protein Kinase C Α Signaling in THP-1 Macrophage-Derived Foam Cells.

Apelin‐13 alleviates osteoclast formation and osteolysis through Nrf2‐pyroptosis pathway

Apelin/APJ Signaling Promotes Hypoxia-Induced Proliferation of Endothelial Progenitor Cells Via Phosphoinositide-3 Kinase/akt Signaling